Home Your basket
• Functional comparison of ...
   Price 14.00 €
• Medicamentous toxic heari...
   Price 5.50 €
• Laryngeal sarcoidosis: Ca...
   Price 5.50 €
• Complete branchial cleft ...
   Price 5.50 €
• Usefulness and limitation...
   Price 10.50 €
• Primary nasal tuberculosi...
   Price 5.50 €
• The verrucous laryngeal c...
   Price 5.50 €
• Cholesterol granuloma of ...
   Price 8.50 €
• Interstitial brachytherap...
   Price 8.50 €
• Evolution of the otology ...
   Price 5.50 €
• Chondrocalcinosis of the ...
   Price 8.50 €
• The outcome of treatments...
   Price 10.50 €
• A clinical respiratory ev...
   Price 10.50 €
• Rare benin tumors of the ...
   Price 5.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Pyogenic granuloma of the...
   Price 8.50 €
• A histopathologic evaluat...
   Price 8.50 €
• Migrant foreign body of t...
   Price 10.50 €
• Surgical management of pa...
   Price 10.50 €
• Prospective evaluation of...
   Price 10.50 €
• Retrosigmoid vestibular n...
   Price 5.50 €
• Disability in patients wi...
   Price 10.50 €
• CT scan, MR imaging and a...
   Price 10.50 €
• Implication of mitochondr...
   Price 10.50 €
• Aesthetic augmentation of...
   Price 10.50 €
• Life after total laryngec...
   Price 8.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• Smile "forced" smile vers...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• Diffuse cervical cellulit...
   Price 10.50 €
• A case of nasal NK/T cell...
   Price 5.50 €
• Overlay versus underlay t...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €

Total Order 296.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2016 o

OTOLOGY

Prevalence of sensineural hearing loss in a popu­­la­tion of diabetics


Authors : Taddrarate Z, Skandour D, Adarmouch L, El Mghari G, Raji A, Amine M, El Ansari N. (Marrakech)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,4:91-94.

Article published in french
Downloadable PDF document french



Summary : Diabetes is a chronic desease carecterized by hyper­glysemia with resounding on micro and macro-vessels. Sensorineural hearing loss in diabetics is secondary to micro vascular damage of the inner ear. It is an unknown micro­angiopathy which causes a vascular hearing loss. The aim of our study was to determine the prevalence of sensorineural hearing loss in a population of non-elderly diabetics. This is a prospective and descriptive study on 89 patients not aged followed for diabetes, spanning a period 1 year, from June 2013 to June 2014. It was sensorineural hearing loss in 85.7% of cases, bilateral in 74.30% of cases. We found isolated high frequency loss in 45.70% of cases and associated with the low-frequency loss in 48.60% of cases. Deafness was classified mild in 54.3%, moderate in 37% of patients. The hearing loss was moderate to severe in 3 cases or 8.6% of sufferers. All patients were asymptomatic. A hearing aid was offered to patients who had severe hearing loss. This work has led us to raise the issue of systematic screening for hearing loss in patients with diabetes.

Price : 14.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE